154
Views
10
CrossRef citations to date
0
Altmetric
Review

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use

ORCID Icon, &
Pages 55-62 | Published online: 10 Jan 2020

Figures & data

Table 1 Safety of Ospemifene and Vaginal Oestrogens on the Risk of Hormone-Dependent Cancer, Venous Thrombosis (VTE) or Cardiovascular Disease (CVD). Summary of the Literature

Table 2 Risk of Side Effects, Discontinuation Rate, Adherence to, Satisfaction with and Overall Related Cost of Treatment with Ospemifene or Vaginal Oestrogens. Summary of the Literature